CEO sold ~$895K of Gilead Sciences
Scheduled in advanceLoading…
Traded Mar 27, 2026 · Filed Mar 30, 2026
The boss of Gilead Sciences sold $1.37M of Gilead Sciences shares. It was planned long ago, so it says very little.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$1,368,162
Shares × reported transaction price
45 days after results of Feb 10, 2026, 41 days before results of May 7, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $134.25 on Mar 27, 2026, 39% above its 52-week low and 14% below its high, after a 12% drop over the previous 30 trading days
52-week range $96.91 (May 9, 2025) to $155.80 (Feb 11, 2026), 63% of the way up, from 251 adjusted closes. 30 trading days earlier: $151.81 on Feb 12, 2026. Describes the past only, not a forecast
A WARN layoff notice covering 51 workers was filed in California on March 25, 2026.
From the official state WARN list, 2 days before the trade; 1 more notice by the company within 60 days. Shown for timing only; the two filings are separate
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | -0.4% | +1.4% | -1.8% |
| 30 days | -6.1% | +10.5% | -16.6% |
| 90 days | -9.4% | +13.9% | -23.3% |
| 180 days | +9.2% | +17.7% | -8.5% |
Past results only. Not a forecast.
CEO sold ~$895K of Gilead Sciences
Scheduled in advanceCEO sold ~$397K of Gilead Sciences
Scheduled in advanceCFO sold ~$423K of Gilead Sciences
Scheduled in advance